{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:27:53Z","timestamp":1760059673001,"version":"build-2065373602"},"reference-count":34,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: International guidelines differ on short-term (4-week) oral anticoagulation (OAC) indication after acute cardioversion for recent-onset atrial fibrillation (AF &lt; 12\u201348 h) in low-risk patients (CHA2DS2-VA = 0). While Canadian and Chinese guidelines recommend OAC for all, European, Australian and New Zealand, and American guidelines state that such treatment is optional due to the absence of high-quality evidence supporting its indication in this specific scenario. This study aimed to assess physicians\u2019 management of a simple clinical case at an international level, focusing on how they balance ischemic and bleeding risks in a setting lacking any strong evidence-based recommendations. Materials and Methods: Six different AF guidelines were evaluated regarding the recommendation for and scientific evidence justifying short-term OAC in this specific setting. Following review, an international questionnaire was developed with Google Forms 2024 (Mountain View, CA, USA) and circulated among physicians working in the fields of cardiology, internal medicine, intensive care unit, geriatrics, and emergency medicine at 17 centres in Italy, France, and Canada. Results: A total of 78 responses were obtained. Younger physicians and cardiologists appeared to administer OAC more frequently compared to older physicians or those working in other specialties (95% CI Fisher\u2019s Exact Test p = 0.049 and 0.029, respectively). Significant differences were observed in the use of periprocedural imaging, with transoesophageal echocardiogram (TOE) prior to cardioversion being performed more often in Europe vs. Canada (p = 0.006) and in long-term rhythm control, with first-line pulmonary vein isolation (PVI) being offered more frequently by European cardiologists (p = 0.013). No statistically significant association was found regarding guideline adherence for OAC administration (p = 0.120). Conclusions: The real-world antithrombotic management of low-risk (CHA2DS2-VA = 0), acutely cardioverted AF patients varies significantly among different healthcare systems. Particularly in cardiology departments, reducing the time limit for safely not prescribing OAC to &lt; 12 h, ensuring local access to direct oral anticoagulants (DOACs) and considering regional stroke risk profiles, as well as actively preventing haemorrhage in patients receiving short-term OAC could all limit cardioversion-related complications in this low-risk population.<\/jats:p>","DOI":"10.3390\/medicina61071200","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T13:06:17Z","timestamp":1751288777000},"page":"1200","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Short-Term Anticoagulation After Cardioversion in New-Onset Atrial Fibrillation and Low Thromboembolic Risk: A Real-World International Investigation"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3191-4875","authenticated-orcid":false,"given":"Alan","family":"Poggio","sequence":"first","affiliation":[{"name":"Department of Clinical and Biological Sciences, MedInTO\u2014Medicine and Surgery, University of Turin, 10125 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5011-2575","authenticated-orcid":false,"given":"Andrew P.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"UBC Division of Cardiology, Gordon & Leslie Diamond Health Care Centre, 2775 Laurel St., 9th Floor, Vancouver, BC V5Z 1M9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Rampa","sequence":"additional","affiliation":[{"name":"Department of Arrhythmology and Electrophysiology, IRCCS Ospedale San Raffaele, 20132 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8493-5123","authenticated-orcid":false,"given":"Jason G.","family":"Andrade","sequence":"additional","affiliation":[{"name":"UBC Division of Cardiology, Gordon & Leslie Diamond Health Care Centre, 2775 Laurel St., 9th Floor, Vancouver, BC V5Z 1M9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6311-4270","authenticated-orcid":false,"given":"Matteo","family":"Anselmino","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medical Sciences, \u201cCitt\u00e0 della Salute e della Scienza di Torino\u201d Hospital, University of Turin, 10125 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"100786","DOI":"10.1016\/j.lanepe.2023.100786","article-title":"Atrial fibrillation: Epidemiology, screening and digital health","volume":"37","author":"Linz","year":"2024","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.15441\/ceem.17.286","article-title":"Effectiveness and safety of electrical cardioversion for acute-onset atrial fibrillation in the emergency department: A real-world 10-year single center experience","volume":"6","author":"Bonfanti","year":"2019","journal-title":"Clin. Exp. Emerg. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.amjcard.2013.10.035","article-title":"Meta-Analysis of Gender Differences in Residual Stroke Risk and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants","volume":"113","author":"Pancholy","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-5273(03)00107-4","article-title":"Atrial stunning: Basics and clinical considerations","volume":"92","author":"Khan","year":"2003","journal-title":"Int. J. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jacc.2013.04.089","article-title":"Thromboembolic Complications After Cardioversion of Acute Atrial Fibrillation","volume":"62","author":"Airaksinen","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1553-2712.2010.00697.x","article-title":"Thirty-day Outcomes of Emergency Department Patients Undergoing Electrical Cardioversion for Atrial Fibrillation or Flutter","volume":"17","author":"Scheuermeyer","year":"2010","journal-title":"Acad. Emerg. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ijcard.2015.10.168","article-title":"Strokes after cardioversion of atrial fibrillation\u2014The FibStroke study","volume":"203","author":"Mustonen","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.cjca.2020.09.001","article-title":"The 2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation","volume":"36","author":"Andrade","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.26599\/1671-5411.2024.03.009","article-title":"Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation","volume":"21","author":"Ma","year":"2024","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Rienstra","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_12","unstructured":"(2024, December 31). Atrial Fibrillation: Diagnosis and Management. Available online: https:\/\/www.nice.org.uk\/guidance\/ng196\/chapter\/Recommendations."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.hlc.2018.06.1043","article-title":"National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018","volume":"27","author":"Brieger","year":"2018","journal-title":"Heart Lung Circ."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1001\/jama.2014.3824","article-title":"Time to Cardioversion for Acute Atrial Fibrillation and Thromboembolic Complications","volume":"312","author":"Nuotio","year":"2014","journal-title":"JAMA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.amjcard.2016.01.024","article-title":"Anticoagulation, CHA2DS2VASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study)","volume":"117","author":"Hartikainen","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jacep.2016.01.018","article-title":"Incidence of Thromboembolic Complications Within 30 Days of Electrical Cardioversion Performed Within 48 Hours of Atrial Fibrillation Onset","volume":"2","author":"Garg","year":"2016","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_18","first-page":"18","article-title":"Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy","volume":"17","author":"Hansen","year":"2015","journal-title":"EP Eur."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11739-016-1589-1","article-title":"Safety of cardioversion in atrial fibrillation lasting less than 48 h without post-procedural anticoagulation in patients at low cardioembolic risk","volume":"13","author":"Tampieri","year":"2018","journal-title":"Intern. Emerg. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jacc.2013.06.019","article-title":"Prevention of Thromboembolism After Cardioversion of Recent-Onset Atrial Fibrillation","volume":"62","author":"Dagres","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/0735-1097(93)90543-A","article-title":"Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: Characterization by simultaneous transesophageal echocardiography","volume":"22","author":"Grimm","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ahj.2004.06.032","article-title":"AFFIRM Investigators Asymptomatic atrial fibrillation: Demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study","volume":"149","author":"Flaker","year":"2005","journal-title":"Am. Heart J."},{"key":"ref_23","unstructured":"(2025, January 08). Prothrombotic markers in atrial fibrillation: What is new?, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/11511115\/."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0735-1097(94)00396-8","article-title":"Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographic study","volume":"25","author":"Stoddard","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijcard.2017.04.014","article-title":"Left atrial appendage thrombi relate to easily accessible clinical parameters in patients undergoing atrial fibrillation transcatheter ablation: A multicenter study","volume":"241","author":"Anselmino","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1017\/cem.2019.487","article-title":"Comment on \u201cThe Canadian Cardiovascular Society 2018 guideline update for atrial fibrillation\u2014A different perspective\u201d","volume":"22","author":"Andrade","year":"2020","journal-title":"CJEM"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e004517","DOI":"10.1161\/JAHA.116.004517","article-title":"Major Bleeding Complications and Persistence with Oral Anticoagulation in Non-Valvular Atrial Fibrillation: Contemporary Findings in Real-Life Danish Patients","volume":"6","author":"Lamberts","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e13316","DOI":"10.1111\/eci.13316","article-title":"Short-term anticoagulation after acute cardioversion of early-onset atrial fibrillation","volume":"50","author":"Saglietto","year":"2020","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_29","first-page":"1502","article-title":"Antithrombotic treatment management in low stroke risk patients un-dergoing cardioversion of atrial fibrillation","volume":"23","author":"Migliore","year":"2021","journal-title":"EP Eur."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.7326\/0003-4819-142-4-200502150-00008","article-title":"Systematic Review: The Relationship between Clinical Experience and Quality of Health Care","volume":"142","author":"Choudhry","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0735-1097(96)00427-5","article-title":"Atrial fibrillation activates platelets and coagulation in a time-dependent manner: A study in patients with paroxysmal atrial fibrillation","volume":"29","author":"Sohara","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"100498","DOI":"10.1016\/j.dmpk.2023.100498","article-title":"Involvement of multiple cytochrome P450 isoenzymes in drug interactions between ritonavir and direct oral anticoagulants","volume":"53","author":"Tamemoto","year":"2023","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_33","unstructured":"American College of Cardiology (2025, February 01). Athletes and Anticoagulation: Return to Play After DVT\/PE. Available online: https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2016\/10\/19\/15\/13\/http%3a%2f%2fwww.acc.org%2flatest-in-cardiology%2farticles%2f2016%2f10%2f19%2f15%2f13%2fathletes-and-anticoagulation."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/a-0892-8151","article-title":"Treatment of venous thoracic inlet syndrome\u2014Specialties in athletes","volume":"49","author":"Weiske","year":"2020","journal-title":"Phlebologie"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1200\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:01:54Z","timestamp":1760032914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["medicina61071200"],"URL":"https:\/\/doi.org\/10.3390\/medicina61071200","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2025,6,30]]}}}